迪安诊断8月30日公告,2023年上半年营收68.42亿元,同比下降36.37%,主要系报告期内医学诊断服务收入减少所致;归母净利润4.53亿元,同比下降75.89%;基本每股收益0.7231元。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.